Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

When she was growing up, food and a clean plate were the center of everything in Tatiana De La Rosa’s life. “If you ever go visit a Hispanic family, they will feed you until you burst,” she tells ...

An Ozempic user has revealed one unexpected side effect that's 'causing issues in their relationship'. While many people are having a lot of success taking GLP-1 drugs such as Ozempic, Mounjaro and ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

In the coming years, the mismatch of revenue growth and expense growth for providers of health care will result in ...

The United States diabetes drugs market size is projected to exhibit a growth rate (CAGR) of 3.55% during 2025-2033. The ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

GoodRx Holdings leverages its patented screening technology to find prescription coupons for uninsured or underinsured ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...